Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT-VTE
NCT05627375Phase 3Recruiting
- Sponsor
- CHU Saint-Etienne
- Start
- Aug 2023
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 3, randomised trial in venous thromboembolism (VTE) (2 arms), sponsored by CHU Saint-Etienne. Primary endpoint: Clinically relevant bleeding at 12 months. Started Aug 2023; status: recruiting.
02
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT05627375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05627375.